BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 22, 2025
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Other news to note for June 30, 2021

June 30, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcuro, Aditum, Ancora, Alligator, Alpine, Athersys, Bioaegis, Biogen, Cenexi, Clover, Cytovation, Dynavax, Elevation, Enochian, Genomic Testing Cooperative, Glaxosmithkline, ICER, Imaginab, Merck & Co., Nimble, Olimmune, Ose, Rayzebio, Scandion, Scopus, Siga, Taisho, Vir.
Read More

In the clinic for June 30, 2021

June 30, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Addex, Astrazeneca, Brim, Celularity, Cerevel, Ciclomed, Compass Pathways, Elicio, F-star, Harmony, Horizon, Iovance, Moderna, Orchard, Pfizer, Propella, Synthetic Biologics, Trillium, VBI.
Read More
European Union map and coronavirus

EMA looking for legal boost to better deal with future pandemics

June 29, 2021
By Nuala Moran
LONDON – Moves to expand the legal remit of the European Medicines Agency (EMA) and give it more powers to deal with the COVID-19 pandemic and future health emergencies are moving to fruition, after the European Parliament and national health ministers in the European Council separately voted through the proposal.
Read More

Other news to note for June 29, 2021

June 29, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Accelerator Applications, Avacta, Avicenna.AI, B. Braun, Bioivt, Cancer Targeted Technology, Cognetivity Neurosciences, Ethicon, Medline Industries, Merck, Neuroloop, Novacyt, Nuance, Orthofix Medical, Qiagen, Teleflex, Valley Biomedical Products & Services, Verogen.
Read More

Regulatory actions for June 29, 2021

June 29, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abiomed, Attana, Front Line Medical, Galderma, Neuros Medical.
Read More
Europe under magnifier/petri dish with coronavirus

COVID-19 therapies advance in EU, not so much a U.S. priority

June 29, 2021
By Mari Serebrov
As a first step in developing a portfolio of COVID-19 therapies, the European Commission identified five promising candidates June 29, including four monoclonal antibodies under rolling review at the EMA and an immunosuppressant that could have its marketing authorization extended to include the treatment of COVID-19 infections.
Read More

Regulatory actions for June 29, 2021

June 29, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Agios, Asklepios, Astrazeneca, Atsena, Biomarin, Biontech, Braeburn, Camurus, Catalyst, Cend, Chugai, Genentech, Immunicum, Innocare, Innovent, Junshi, Kymera, Moderna, Oric, Pfizer, Regeneron, Roche, Rockwell, Saniona, Sanofi, Syndax, Zentalis.
Read More

Other news to note for June 29, 2021

June 29, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acrivon, Amgen, Antios, Applied Biomath, APR, Arbutus, Astrazeneca, Baymedica, Brigham and Women's Hospital, Cannex, Carmot, Cell and Gene Therapy Catapult, Compugen, Curie Institute, Defence, Diurnal, Elevatebio, E r-Kim, Etherna, Ichnos, Inmed, Innovent, Ixaka, KBI, Lilly, Mosaic Biosciences, Mosaic Immunoengineering, Ocular, Paratek, PYC, Q-State, Quantoom, Relief, Selexis, Simcere, Somalogic, Synaffix, Vivoryon.
Read More

In the clinic for June 29, 2021

June 29, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Achieve, Clovis, Dare, Hoth, Ideaya, Intellia, Kymera, Maat, Neurophth, Onconova, Pinteon, Precision Biosciences, Regenerative Patch, Regeneron, RDIF, Rigel, Sab, Sanofi, Springworks, Zentalis.
Read More

Other news to note for June 28, 2021

June 28, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Asensus Surgical US, DNA Diagnostics Center, Eurofins Scientific, Meridian Bioscience, Newpace, Powermat Technologies, Red One Medical, Rockwell Medical.
Read More
Previous 1 2 … 215 216 217 218 219 220 221 222 223 … 551 552 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing